Centers for Disease Control and Prevention, Emerging Infectious Diseases, 2(23), p. 328-331
Full text: Download
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro.